Gridai Technologies Corp. (GRDX) fundamentals score
GridAI Technologies Corp., formerly known as Entero Therapeutics, Inc., is a diversified technology and life sciences company operating through two principal areas: (i) energy orchestration and grid optimization software solutions through its subsidiary Grid AI Corp. and (ii) legacy biopharmaceutical development activities centered on Adrulipase for the treatment of exocrine pancreatic insufficiency.
Utilities, Electric & Other Services Combined · Utilities · Listed on NASDAQ
Overall: 3.6 out of 10, Weak long-term fundamentals
- Growth: 3.5/10
- Profitability: 1.2/10
- Financial health: 5.1/10
- Earnings quality: 7.8/10
- Valuation: 1.5/10
Scores are calculated from Gridai Technologies Corp.’s SEC filings, using the 12 months through 2025-12. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Utilities stocks
- Cheniere Energy Partners, L.P. (CQP): 7.5/10
- Excelerate Energy, Inc. (EE): 7.3/10
- Pure Cycle Corporation (PCYO): 7.3/10
- The Aes Corporation (AES): 7.2/10
- Waste Connections, Inc. (WCN): 7.2/10
- National Fuel Gas Co. (NFG): 7.1/10
- Consolidated Water Co. Ltd. (CWCO): 6.9/10
- Waste Management Inc. (WM): 6.8/10